COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics fera une présentation lors de la 21e conférence mondiale annuelle sur les investissements de Rodman & Renshaw
28/08/2019
VANCOUVER, Colombie-Britannique, 28 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a annoncé aujourd'hui qu'elle présentera un aperçu de l'entreprise et sera [...]
Medtronic Announces Planned Leadership Succession
28/08/2019
Omar Ishrak Will Retire as CEO at End of Fiscal Year; Remains Chairman of the Board and Becomes Executive Chairman of Medtronic Geoff Martha, EVP of the Restorative Therapies Group, Appointed Medtronic President, and [...]
Teleflex to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
28/08/2019
WAYNE, Pa., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 17 th Annual Global Healthcare Conference at the Grand Hyatt in [...]
Precision BioSciences to Present at Upcoming Investor Conferences
28/08/2019
DURHAM, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its pioneering, proprietary ARCUS [...]
Exactus Inc. Provides Hemp Farm Update and Will Begin Taking Orders for Triple A Top Flower
28/08/2019
DELRAY BEACH, Fla., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it is on track to exceed its [...]
Amarin to Participate in the H.C. Wainwright 21st Annual Global Investment Conference
28/08/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
28/08/2019
This is an unofficial in-house translation of the Swedish original. In case of differences the Swedish version shall prevail. The shareholders of Oasmia Pharmaceutical AB are hereby given notice of the Annual General [...]
TLC to Present at Upcoming Investor Conferences in September 2019
28/08/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 28, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152) today announced that the management team is scheduled to present at the two upcoming investor conferences: [...]
Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
28/08/2019
Company announcement – No. 27 / 2019 Copenhagen, August 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development [...]
Affimed to Participate in Investor Conferences in September
28/08/2019
Heidelberg, Germany, August 28, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced its participation in [...]
LIDDS: Liproca® Depot Phase IIb results to be presented as “Late Breaking News” at EMUC in Vienna on November 16, 2019
28/08/2019
Professor Laurence Klotz, a world leading expert in Active Surveillance of prostate cancer patients, will present the results of the LPC-004 prostate cancer study at the 11th European Multidisciplinary Congress on [...]
Olainfarm invites to Second Quarter 2019 Investor Conference Webinar
28/08/2019
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 3, 2019 at 16:00 (EEST). To join the webinar please follow [...]
Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited)
28/08/2019
Herantis Pharma Plc Company release August 28, 2019 at 9:00am Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited) Randomized clinical studies in Parkinson’s and lymphedema [...]
Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
28/08/2019
Company announcement – No. 27 / 2019 Copenhagen, August 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development [...]
Orphazyme announces Interim Report First Half 2019
28/08/2019
Company announcement Orphazyme A/S No. 26/2019 Company Registration No. 32266355 Copenhagen, Denmark, August 28, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments [...]
PCI Biotech: Second quarter and first half 2019 results
28/08/2019
Oslo (Norway), 28 August 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its second quarter and first half 2019 result. Please find enclosed the report and presentation. First [...]
Mesoblast to Host Analyst Call on 2019 Financial Results for Year and Fourth Quarter Ended June 30, 2019
28/08/2019
NEW YORK and MELBOURNE, Australia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will host a webcast to discuss the financial [...]
Scholar Rock Announces Upcoming Departure of Chief Financial Officer
27/08/2019
CAMBRIDGE, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (Nasdaq: SRRK), a clinical stage biopharmaceutical company, announced today that its Chief Financial Officer, Rhonda Chicko, will be [...]
Opiant Pharmaceuticals Announces Presentations at Two Upcoming Investor Conferences
27/08/2019
SANTA MONICA, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, will present at [...]

Pages